Mosquito Saliva Alone Triggers Unexpected Immune Response

Mosquito season is around the corner, bringing with it a higher risk of catching potentially serious diseases transmitted by their bite. Mosquitoes also may increase the severity of the diseases they transmit, and researchers think that mosquito saliva plays an active role in this process. A team of researchers at Baylor College of Medicine has taken a closer look at the effect of mosquito saliva alone and found that it can trigger an unexpected variety of immune responses in an animal model of the human immune system. These results offer an opportunity to develop effective strategies to prevent mosquito-based transmission of disease. The study appears in the journal PLOS Neglected Tropical Diseases.

“Billions of people worldwide are exposed to diseases transmitted by mosquitoes, and many of these conditions do not have effective treatments,” said corresponding author Dr. Rebecca Rico-Hesse, professor of molecular virology and microbiology at Baylor College of Medicine. “One of the interests of my lab is to study the development of dengue fever, which is caused by the dengue virus transmitted by mosquito Aedes aegypti.”

The World Health Organization has estimated that 100 million dengue virus infections and 22,000 deaths occur yearly worldwide, mostly among children. According to the Centers for Disease Control and Prevention, more than one-third of the world’s population lives in areas at risk of infection, making the dengue virus a leading cause of illness and death in the tropics and subtropics.

“One of the main limitations for studying dengue fever is that the dengue virus only causes the disease in humans; no other animals can be used as models of the condition to develop preventive and therapeutic measures,” Rico-Hesse said. “To overcome this challenge, we have been working with a mouse model of the human immune system.”

These ‘humanized mice’ were developed by other research groups from mice naturally born without their own immune system. These severely immunodeficient mice received human stem cells that gave rise to many of the components of the human immune system, creating a living humanized animal model in which Rico-Hesse and her colleagues can study factors that may affect the development of dengue fever.

“In 2012, we demonstrated in these humanized mice that mosquito-bite delivery and needle-injection delivery of dengue virus led to significantly different disease developments,” Rico-Hesse said. “Importantly, mosquito-bite delivery of the virus resulted in a more human-like disease than the one we observed after needle-injection delivery of the virus. When the mosquitoes delivered the virus, the mice had more of a rash, more fever and other characteristics that mimic the disease presentation in humans.”

These observations support the idea that mosquitoes are not just acting like ‘syringes,’ merely injecting viruses into the animals they feed on. Their saliva seems to contribute significantly to the development of the disease, which has prompted Rico-Hesse and her colleagues to investigate what this role might be. They began by determining the effect of bites from virus-free mosquitoes on the human immune response of humanized mice.

To test the effect of virus-free mosquito saliva on humanized mice, the researchers held a vial containing mosquitoes against a footpad of anesthetized humanized mice, allowing a total of four mosquitoes to feed on both footpads.

The researchers then took blood and a number of other tissue samples six hours, 24 hours and seven days after the mosquitoes bit the mice, and determined the levels of cytokines, molecules that modulate the immune response, as well as the number and activity of different types of immune cells. They compared these results with those obtained from humanized mice that had not been bitten by mosquitoes.

To make the above determinations, the researchers used highly-sensitive techniques – flow cytometry for immune cell analysis and multiplex cytokine bead array analysis for cytokines – that allowed them to dissect the immune responses in great detail. This approach produced surprising results.

“We found that mosquito-delivered saliva induced a varied and complex immune response we were not anticipating,” said co-author Dr. Silke Paust, assistant professor of pediatrics at Baylor and Texas Children’s Hospital. “For instance, both the immune cell responses and the cytokine levels were affected. We saw activation of T helper cells 1, which generally contribute to antiviral immunity, as well as activation of T helper cells 2, which have been linked to allergic responses.”

At various time points, the levels and activities of other types of immune cells also increased as others decreased. Overall, the researchers found evidence that mosquito saliva alone can trigger long-lasting immune responses – up to seven days post-bite – in multiple tissue types, including blood, skin and bone marrow.

“The diversity of the immune response was most striking to me. This is surprising given that no actual infection with any type of infectious agent occurred,” said Paust, who also is a member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. “These results are evidence that components in the mosquito saliva can modulate the immune response in humanized mice.”

The researchers will continue this study by investigating which of the more than 100 proteins in mosquito saliva are mediating the effects on the immune system, or may help the virus become more infectious. Identifying these proteins could help design strategies to fight transmission of dengue fever, as well as other diseases caused by viruses also transmitted by Aedes aegypti, such as Zika virus, chikungunya virus and yellow fever virus.

“We hope that our work will inspire more research in this area with the long-term goal of using our understanding of how saliva manipulates the immune system for therapeutic purposes,” said Paust.

Other contributors of this work include Megan B. Vogt, Anismrita Lahon, Ravi P. Arya, Alexander R. Kneubehl and Jennifer L. Spencer Clinton, all at Baylor College of Medicine.

Financial support for this study was provided by National Institutes of Health grants.

Source: Baylor College of Medicine